Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeting GCGR signaling pathway counteracts PI3K inhibitor-induced hyperglycemia

Dec. 28, 2020

Abionyx launches phase IIa study of CER-001 for prevention of AKI in septic patients

Dec. 24, 2020

FDA issues a Study May Proceed letter for phase Ib trial of CX-5461

Dec. 24, 2020

First-in-human data presented for AMG-701 in relapsed/refractory multiple myeloma

Dec. 24, 2020

Adipocyte telomere length controls susceptibility to diabetes

Dec. 24, 2020

A2 Biotherapeutics and Merck collaborate to develop novel allogeneic cell therapy

Dec. 24, 2020

FDA issues clinical hold on IND application for AdCOVID

Dec. 24, 2020

Health Canada authorizes Moderna's COVID-19 vaccine

Dec. 24, 2020

FDA approves international phase III study of carrimycin in patients with severe COVID-19

Dec. 24, 2020

Verseau Therapeutics describes new anti-SIGLEC9 antibodies

Dec. 24, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...